PEspeaks

Sep 07, 2012
Pharmaceutical Executive
The Access to Medicines Index is an attempt to measure and compare the corporate social responsibility of both innovator (20) and generics (7) companies based on a number of different (and often quixotic) indicators.
Sep 07, 2012
Pharmaceutical Executive
The Senate Special Committee on Aging is holding a Roundtable discussion on Wed. Sept. 12.
Sep 06, 2012
Pharmaceutical Executive
The pharmaceutical industry still lags other industries in spending on outbound social media programs that engage customers directly.
Sep 05, 2012
Pharmaceutical Executive
The FDA and the Advanced Medical Technology Association (AdvaMed) gave cardiovascular device manufacturers plenty to think about over the holiday weekend with information presented at an Aug. 28 workshop.
Aug 31, 2012
Pharmaceutical Executive
It’s something of an enigma that most physicians are keen to learn about and use cutting edge medicines and devices for their patients.
Aug 29, 2012
Pharmaceutical Executive
The European Union is at last groping its way towards some form of standardization in judging the value of medicines.
Aug 29, 2012
Pharmaceutical Executive
The European Union is at last groping its way towards some form of standardization in judging the value of medicines.
Aug 29, 2012
Pharmaceutical Executive
Public policy activities should be a distinct, mission critical function for Big Pharma — our business depends increasingly on government as a key customer.
Aug 29, 2012
Pharmaceutical Executive
In the American version of the Australian TV series Wilfred, the show’s title character declares that for him, human life begins at 10 years old.
Aug 22, 2012
Pharmaceutical Executive
Well, we certainly have a presidential campaign now, don’t we? Good grief. Since Rep. Paul Ryan was named the Republican VP candidate last week.
native1_300x100
lorem ipsum